Clinical Trials · NCT00452556
The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Nova Scotia Cancer Centre
- Enrollment
- 86
- Start date
- May 2007
- Locations
- 1 site, Canada
- Primary endpoint
- To investigate if the inversion of sequencing of multi - phase, intensity - modulated radiotherapy (IMRT), for the treatment of patients with high - risk prostate cancer, can improve the delivery of concurrent, weekly Docetaxel chemotherapy, in conc